Tags |
|
|
Links |
|
|
Top Adding - Plant Patents
This article will give you a breakdown of what a plant patent is.
The first type of patent is called a plant patent. It is usually given to people who have invented a
The first type of patent is called a plant patent. It is usually given to people who have invented a
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
new plant hybrid. It is also given when a new variety of plant has been discovered, and the person has successfully been able to reproduce it. Not every plant can be
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
patented; for example, the Patent Office will not issue a patent for a tuberous plant. A plant patent is usually given for a duration of twenty years.
A plant is cons
A plant is cons
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
idered by the Patent and Trademark Office as being living thing that has its own natural composition. The natural composition of a plant is made possible by the genes
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
the plant possess. These genes can be reproduced in an asexual capacity, allowing the genes to be transferred to daughter plants.
The most common forms of plants gran
The most common forms of plants gran
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ed patents are mutants, hybrid plants, and plants which have undergone a type of transformation. A mutant plant can be from one of two sources discovered naturally,
ucts have become life saving products for the pharmaceutical companies who doesnt have many innovative molecules in their product pipeline and have been inc
or created. The same is true of hybrids, which can be found in nature or created intentionally.
The general guidelines for determining whether a plant is suitable for
The general guidelines for determining whether a plant is suitable for
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
patenting are as follows:
The plant should be different from any other plant that already exists, with at least one change in its composition. When compared with a
The plant should be different from any other plant that already exists, with at least one change in its composition. When compared with a
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
nother plant that is a relative, the potential patented plant should have at least one thing different about it.
The plant must be new. It can be considered ne
The plant must be new. It can be considered ne
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
w either by having been created in a nursery or greenhouse, or new because of its discovery in nature.
A newly discovered plant, or one that has been created,
A newly discovered plant, or one that has been created,
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
an only enter into the patent application process if the person who first discovered or created it, makes the application.
At the time of the application, othe
At the time of the application, othe
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
r people in the plant industry must not have thought it an obvious invention.
The plant can not previously have been offered for sale prior to the patent appli
The plant can not previously have been offered for sale prior to the patent appli
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
cation.
The plant can not have been available to the public for more than one year prior to the patent application. This one year limitation includes the sale
The plant can not have been available to the public for more than one year prior to the patent application. This one year limitation includes the sale
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
of the plant, but also the description of the plant in a publication, such as a botany journal.
In order to quality for a plant patent, the applicant must have succes
In order to quality for a plant patent, the applicant must have succes
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
sfully reproduced the plant via asexual methods. Many people are not sure of what asexual reproduction means, but generally it results in a next generation of plants t
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
at are an exact replica, in appearance and genes, as the mother plant. This is in contrast to reproduction in a sexual way, in which the offspring are not an exact rep
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
lica. Animals engage in sexual reproduction, and offspring varies in appearance from their parents. Examples of what the Patent Office considers to be asexual reproduc
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
tion in plants include bulbs, grafts, runners, cuttings from roots, plants created in the layering process, or corms.
Other than using photographs, some people seekin
Other than using photographs, some people seekin
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
g plant patents use regular colored drawings to show the Patent Office the plant they are describing--even hiring a professional artist to produce these drawings for t
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
hem. In this aspect, plant patents have both components to design and utility patents.
You now have the knowledge that you need to decide if a plant patent is for you
You now have the knowledge that you need to decide if a plant patent is for you
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.topadding.org.ua/article/130696/topadding-Plant-Patents.html">Plant Patents</a>
BB link (for phorums):
[url=http://www.topadding.org.ua/article/130696/topadding-Plant-Patents.html]Plant Patents[/url]
Related Articles:
How To Get A Job Writing Speeches
Developing a Team or Organization Vision
The 3 Golden Rules Professional Graphic Designers Don't Want You to Know About
Bookmark it:
|